Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Resignation of Ms Maithilee Mistry as Whole-time Director and CFO of the company w.e.f. May 05, 2025.
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts more than Nifty Microcap 250 and 3.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sanofi Consumer Healthcare India has informed the exchanges that Ms. Maithilee Mistry, who served as both Whole-time Director and Chief Financial Officer, has resigned to explore opportunities outside the company. Her last working day will be May 5, 2025. Separately, Mr. Rupendra Sachdev, Head of Commercial Operations and a Senior Management Personnel, is also stepping down to pursue entrepreneurial ventures, with his last working day set for April 30, 2025. Both departures are voluntary and personal in nature, and the company has acknowledged their contributions. No successor names or interim arrangements have been announced in this filing.
Losing the CFO and a senior commercial head within weeks of each other may create short-term leadership uncertainty for a relatively newly listed consumer healthcare entity. Investors will look out for timely succession announcements; near-term stock reaction is likely muted unless succession is delayed or raises governance concerns.